Aquestive Therapeutics (AQST) Institutional Ownership

$4.66 +0.17 (+3.79%)

As of 08/21/2026 04:00 PM Eastern

Current Institutional Ownership Percentage: 32.45%
Number of Institutional Buyers (last 12 months): 114
Total Institutional Inflows (last 12 months): $207.61M

Number of Institutional Sellers (last 12 months): 33
Total Institutional Outflows (last 12 months): $43.49M

Get AQST Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aquestive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AQST Institutional Buying and Selling by Quarter

Aquestive Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/21/2026	AXQ Capital LP	28,100	$117K	0.0%	-41.4%	0.022%
8/20/2026	Wedbush Securities Inc.	14,500	$60K	0.0%	N/A	0.012%
8/19/2026	Wellington Management Group LLP	301,647	$1.26M	0.0%	+4.0%	0.240%
8/18/2026	Beacon Pointe Advisors LLC	60,500	$252K	0.0%	N/A	0.048%
8/17/2026	Pure Financial Advisors LLC	20,222	$84K	0.0%	N/A	0.016%
8/17/2026	Bank of America Corp DE	1,668,423	$6.94M	0.0%	N/A	1.329%
8/15/2026	Man Group plc	351,700	$1.46M	0.0%	N/A	0.280%
8/15/2026	AWM Investment Company Inc.	475,400	$1.98M	0.2%	N/A	0.379%
8/14/2026	Legal & General Group Plc	10,492	$44K	0.0%	N/A	0.008%
8/14/2026	The Manufacturers Life Insurance Company	29,270	$122K	0.0%	N/A	0.023%
Get the Latest News and Ratings for AQST and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aquestive Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/12/2026	Elevation Point Wealth Partners LLC	10,100	$42K	0.0%	N/A	0.008%
8/12/2026	Quantbot Technologies LP	23,707	$99K	0.0%	N/A	0.019%
8/11/2026	Bratton Capital Management L.P.	9,810,958	$40.81B	100.0%	N/A	7.819%
8/11/2026	Keating Financial Advisory Services Inc.	12,563	$52K	0.0%	N/A	0.010%
8/11/2026	Blue Owl Capital Holdings LP	942,932	$3.92M	0.6%	N/A	0.752%
8/11/2026	Latash Investments LLC	243,134	$1.01M	0.7%	N/A	0.194%
8/8/2026	Wealthfront Advisers LLC	10,679	$44K	0.0%	N/A	0.009%
8/7/2026	BlackRock Inc.	8,069,373	$33.57M	0.0%	N/A	6.431%
8/7/2026	Deutsche Bank AG	106,028	$441K	0.0%	N/A	0.085%
8/7/2026	HBK Sorce Advisory LLC	42,547	$160K	0.0%	N/A	0.034%
8/6/2026	Bank of New York Mellon Corp	275,544	$1.15M	0.0%	N/A	0.220%
8/6/2026	GSA Capital Partners LLP	116,260	$484K	0.0%	N/A	0.093%
8/3/2026	Walleye Capital LLC	282,568	$1.18M	0.0%	N/A	0.225%
7/10/2026	Wasatch Advisors LP	1,385,843	$5.77M	0.0%	+57.8%	1.105%
5/22/2026	Verus Capital Partners LLC	51,625	$214K	0.0%	-15.1%	0.041%
5/20/2026	Arete Wealth Advisors LLC	121,485	$504K	0.0%	N/A	0.097%
5/19/2026	Bank of America Corp DE	2,405,050	$9.98M	0.0%	+99.2%	1.917%
5/19/2026	Arete Wealth Advisors LLC	121,485	$504K	0.0%	N/A	0.097%
5/18/2026	ADAR1 Capital Management LLC	10,000	$42K	0.0%	-103.9%	0.008%
5/18/2026	Royal Bank of Canada	28,951	$120K	0.0%	+133.0%	0.023%
5/16/2026	The Manufacturers Life Insurance Company	27,922	$116K	0.0%	-12.0%	0.022%
5/16/2026	Quantinno Capital Management LP	18,014	$75K	0.0%	+52.8%	0.014%
5/15/2026	Corsair Capital Management L.P.	70,000	$290K	0.0%	+16.7%	0.056%
5/14/2026	Sei Investments Co.	24,845	$103K	0.0%	-87.5%	0.020%
5/14/2026	Walleye Capital LLC	584,977	$2.43M	0.0%	+103.3%	0.471%
5/6/2026	Independent Financial Group LLC	15,750	$65K	0.0%	N/A	0.013%
5/5/2026	Wealthfront Advisers LLC	12,127	$50K	0.0%	N/A	0.010%
5/5/2026	Bank of New York Mellon Corp	255,184	$1.06M	0.0%	-5.4%	0.205%
5/4/2026	Bleakley Financial Group LLC	135,767	$563K	0.0%	N/A	0.109%
5/2/2026	International Assets Investment Management LLC	22,895	$95K	0.0%	+27.0%	0.018%
These gold assets are priced for $1,800 gold [it's over $4,000] (Ad) Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production. See the junior gold assets majors may target next
4/27/2026	Simplify Asset Management Inc.	234,279	$972K	0.0%	N/A	0.192%
4/27/2026	PFG Investments LLC	31,101	$129K	0.0%	-10.6%	0.025%
4/27/2026	Y Intercept Hong Kong Ltd	26,992	$112K	0.0%	N/A	0.022%
4/27/2026	Elevation Point Wealth Partners LLC	10,100	$42K	0.0%	N/A	0.008%
4/22/2026	Janney Montgomery Scott LLC	1,089,110	$4.52M	0.0%	-0.4%	0.892%
4/21/2026	Wasatch Advisors LP	878,316	$3.65M	0.0%	+28.9%	0.720%
4/21/2026	Sugar Maple Asset Management LLC	58,060	$241K	0.1%	+5.9%	0.048%
4/21/2026	Penbrook Management LLC	25,565	$106K	0.1%	-39.4%	0.021%
4/17/2026	Everstar Asset Management LLC	553,181	$2.30M	1.2%	+60.4%	0.453%
3/17/2026	Rockefeller Capital Management L.P.	17,196	$111K	0.0%	-51.6%	0.014%
2/19/2026	Invesco Ltd.	64,993	$420K	0.0%	+20.2%	0.053%
2/18/2026	Voloridge Investment Management LLC	194,105	$1.25M	0.0%	N/A	0.159%
2/18/2026	Wellington Management Group LLP	270,976	$1.75M	0.0%	-5.2%	0.222%
2/18/2026	Numerai GP LLC	122,125	$789K	0.1%	N/A	0.100%
2/18/2026	Occudo Quantitative Strategies LP	56,545	$365K	0.0%	N/A	0.046%
2/18/2026	Perceptive Advisors LLC	747,193	$4.83M	0.1%	-80.1%	0.612%
2/18/2026	Millennium Management LLC	1,535,369	$9.92M	0.0%	+19.1%	1.258%
2/18/2026	Man Group plc	29,213	$189K	0.0%	N/A	0.024%
2/18/2026	Janus Henderson Group PLC	226,702	$1.46M	0.0%	N/A	0.186%
2/18/2026	Balyasny Asset Management L.P.	970,939	$6.27M	0.0%	+94.2%	0.796%
2/18/2026	Bridgeway Capital Management LLC	64,900	$419K	0.0%	-4.1%	0.053%
2/17/2026	Schonfeld Strategic Advisors LLC	18,804	$121K	0.0%	-35.0%	0.015%
2/17/2026	AQR Capital Management LLC	61,709	$399K	0.0%	+6.8%	0.051%
2/17/2026	Abel Hall LLC	11,496	$74K	0.0%	N/A	0.009%
2/17/2026	Trexquant Investment LP	523,334	$3.38M	0.0%	N/A	0.429%
2/17/2026	Jump Financial LLC	246,840	$1.60M	0.0%	+1,098.4%	0.202%
2/17/2026	Price T Rowe Associates Inc. MD	55,951	$362K	0.0%	+24.1%	0.046%
2/17/2026	Osaic Holdings Inc.	79,703	$515K	0.0%	-45.4%	0.065%
2/17/2026	Corsair Capital Management L.P.	60,000	$388K	0.1%	N/A	0.049%
2/17/2026	California State Teachers Retirement System	100,819	$651K	0.0%	+1,772.2%	0.083%
2/17/2026	Russell Investments Group Ltd.	209,430	$1.35M	0.0%	+28.2%	0.172%
2/17/2026	State of Wisconsin Investment Board	181,511	$1.17M	0.0%	+24.3%	0.149%
2/17/2026	Royal Bank of Canada	12,426	$80K	0.0%	-96.6%	0.010%
2/16/2026	Verition Fund Management LLC	160,197	$1.04M	0.0%	N/A	0.131%
2/16/2026	Barclays PLC	340,807	$2.20M	0.0%	+158.7%	0.279%
2/13/2026	Walleye Capital LLC	287,811	$1.86M	0.0%	-43.0%	0.236%
2/13/2026	Stifel Financial Corp	369,728	$2.39M	0.0%	+0.9%	0.303%
2/13/2026	Rafferty Asset Management LLC	25,426	$164K	0.0%	N/A	0.021%
2/13/2026	Charles Schwab Investment Management Inc.	301,521	$1.95M	0.0%	+18.6%	0.247%
2/13/2026	State Street Corp	2,462,778	$15.91M	0.0%	+53.7%	2.019%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	120,252	$777K	0.0%	N/A	0.099%
2/13/2026	Wells Fargo & Company MN	1,188,531	$7.68M	0.0%	+804.6%	0.974%
2/12/2026	Wasatch Advisors LP	681,240	$4.40M	0.0%	-5.9%	0.558%
2/12/2026	HRT Financial LP	994,966	$6.43M	0.0%	+77.6%	0.816%
2/12/2026	DRW Securities LLC	17,128	$111K	0.0%	N/A	0.014%
2/12/2026	MetLife Investment Management LLC	58,161	$376K	0.0%	+19.5%	0.048%
2/12/2026	Commonwealth Equity Services LLC	1,019,792	$6.59M	0.0%	-3.7%	0.836%
2/12/2026	Renaissance Technologies LLC	414,400	$2.68M	0.0%	+376.3%	0.340%
2/12/2026	Federated Hermes Inc.	2,032,822	$13.13M	0.0%	+159.4%	1.666%
2/12/2026	Informed Momentum Co LLC	155,053	$1.00M	0.1%	+1.8%	0.127%
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today
2/12/2026	New York State Common Retirement Fund	27,300	$176K	0.0%	+123.8%	0.022%
2/12/2026	Bank of Montreal Can	64,697	$418K	0.0%	+239.6%	0.053%
2/12/2026	Swiss National Bank	202,700	$1.31M	0.0%	N/A	0.166%
2/12/2026	Nuveen LLC	364,016	$2.35M	0.0%	-33.2%	0.298%
2/11/2026	Janney Montgomery Scott LLC	1,093,210	$7.06M	0.0%	-0.6%	0.896%
2/11/2026	Deutsche Bank AG	83,429	$539K	0.0%	+11.5%	0.068%
2/11/2026	Letko Brosseau & Associates Inc.	35,325	$228K	0.0%	N/A	0.029%
2/11/2026	Fox Run Management L.L.C.	34,518	$223K	0.0%	N/A	0.028%
2/11/2026	LPL Financial LLC	102,388	$661K	0.0%	+13.9%	0.084%
2/11/2026	Los Angeles Capital Management LLC	68,200	$454K	0.0%	N/A	0.056%

AQST Institutional Ownership - Frequently Asked Questions

During the previous two years, 168 institutional investors and hedge funds held shares of Aquestive Therapeutics. The most heavily invested institutionals were Bratton Capital Management L.P. ($40.81B), BlackRock Inc. ($33.57M), Vanguard Group Inc. ($31.65M), State Street Corp ($15.91M), Geode Capital Management LLC ($15.30M), Federated Hermes Inc. ($13.13M), and Millennium Management LLC ($9.92M).Learn more on Aquestive Therapeutics' institutional investors.

32.45% of Aquestive Therapeutics' stock is owned by institutional investors. Learn more on AQST's institutional investor holdings.

Of the 153 institutional investors that purchased Aquestive Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bratton Capital Management L.P. ($9.81M), BlackRock Inc. ($8.07M), Bank of America Corp DE ($3.49M), Federated Hermes Inc. ($2.03M), Wasatch Advisors LP ($1.43M), Vanguard Group Inc. ($1.42M), and State Street Corp ($1.37M).

Institutional investors have bought a total of 42,268,971 shares in the last 24 months. This purchase volume represents approximately $207.61M in transactions.

Of the 33 institutional investors that sold Aquestive Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($3.01M), Millennium Management LLC ($1.69M), Blue Owl Capital Holdings LP ($725K), Royal Bank of Canada ($350.98K), Walleye Capital LLC ($217.46K), Nuveen LLC ($180.60K), and Financial Engines Advisors L.L.C. ($176.93K).

Institutional investors have sold a total of 7,105,237 shares in the last 24 months. This volume of shares sold represents approximately $43.49M in transactions.

Related Companies

Institutional ownership data for NASDAQ:AQST is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/21/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aquestive Therapeutics (AQST) Institutional Ownership

AQST Institutional Buying and Selling by Quarter

Aquestive Therapeutics Major Shareholders & Ownership History

AQST Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aquestive Therapeutics (AQST) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Aquestive Therapeutics (NASDAQ:AQST)

AQST Institutional Buying and Selling by Quarter

Aquestive Therapeutics Major Shareholders & Ownership History

AQST Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AQST shares?

What percentage of Aquestive Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Aquestive Therapeutics' stock?

How much institutional buying is happening at Aquestive Therapeutics?

Which of Aquestive Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Aquestive Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools